Skip to content

#CDK inhibitor

3 public questions tagged with this topic.

The role of p27 in G1 phase is to:

p27Kip1 product of CDKN1B gene exemplifies Cip/Kip family that imposes G1 arrest and integrates nutrient availability with size control. In quiescent and early G1 cells, p27 accumulates due to low proteasomal turnover and binds cyclin E-CDK2 heterodimer, inserting 3_10 helix into ATP-binding pocket, preventing catalysis and blocking Rb phosphorylation, maintaining E2F repression. This prevents premature S-phase entry when growth factors limited. Mitogen signaling induces cyclin D-CDK4/6 complexes that sequester p27 in trimeric assembly without fully inhibiting them, lowering free p27 pool. Subsequent phosphorylation of p27 at threonine 187 by progressively activated cyclin E-CDK2 creates high-affinity phosphodegron recognized by F-box protein Skp2 assembled in SCF complex with Skp1, Cul1, Rbx1, and accessory Cks1. SCF-Skp2 polyubiquitinates p27 targeting it to 26S proteasome. Declining p27 levels unleash full CDK2 activity, hyperphosphorylating Rb and committing to DNA replication when nutrient conditions favorable. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Sherr & Roberts, Genes & Dev 2004, p27 Biology. Morgan, Cell Cycle, Chapter 4, G1 Control.

The protein p16 (INK4) primarily inhibits:

INK4 family represents dedicated inhibitors of CDK4 and CDK6 distinguishing them from Cip/Kip family that target cyclin E-CDK2 and cyclin A-CDK2. p16INK4a product of CDKN2A locus contains four ankyrin repeats forming elongated structure that binds CDK6 opposite cyclin-binding interface, inducing distortion of ATP-binding pocket and preventing association with cyclin D. Since cyclin D-CDK4/6 is earliest kinase phosphorylating Rb in response to mitogens, its inhibition maintains Rb in hypophosphorylated active repressor state bound to E2F, arresting cell before restriction point. Genetic inactivation through homozygous deletion, nonsense mutation, or promoter CpG hypermethylation occurs at high frequency in melanoma familial syndromes, pancreatic ductal adenocarcinoma, glioblastoma multiforme, and esophageal cancers, leading to uncontrolled Rb phosphorylation. Clinically, pharmacologic mimics of p16 action including palbociclib, ribociclib, and abemaciclib selectively inhibit CDK4/6, restoring Rb function and inducing G1 arrest in estrogen receptor-positive breast cancer, demonstrating translational exploitation. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Sherr & Roberts, Genes & Dev 1999, INK4 Family Biology. Alberts 7th ed., Chapter 20.

The major function of p21 in the cell cycle is to:

p21WAF1/CIP1 encoded by CDKN1A represents broad-spectrum cyclin-dependent kinase inhibitor linking DNA damage response to cell cycle arrest in G1 and G2. Upon double-strand break detection, ATM kinase phosphorylates Chk2 and p53 at serine 15, blocking MDM2-mediated ubiquitination and stabilizing p53. ATR responds to single-stranded DNA coated with RPA. Accumulated p53 binds response elements in CDKN1A promoter, markedly upregulating p21 protein that contains N-terminal CDK inhibitory domain with Cy1 and Cy2 cyclin-binding motifs. p21 inserts into catalytic cleft of cyclin E-CDK2, cyclin D-CDK4/6, and cyclin B-CDK1, blocking ATP binding and preventing phosphorylation of Rb and mitotic substrates. Arrest provides window for base excision repair, nucleotide excision repair, and homologous recombination to restore template integrity before replication or segregation. p21 also directly binds proliferating cell nuclear antigen PCNA, pausing processive DNA synthesis at damaged forks without abolishing repair synthesis. Loss of p21 permits replication of damaged DNA, propagating mutations. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Alberts et al., Molecular Biology of the Cell, 7th ed., Chapter 17: p53-p21 DNA Damage Axis.